Skip to main content
Clinical Trials/NCT02884440
NCT02884440
Completed
Phase 2

Transverse Abdominis Plane Block for Anterior Approach Spine Surgery: A Prospective Randomized Study

Rennes University Hospital1 site in 1 country43 target enrollmentNovember 7, 2016

Overview

Phase
Phase 2
Intervention
TAP block ropivacaine
Conditions
Spine Surgery
Sponsor
Rennes University Hospital
Enrollment
43
Locations
1
Primary Endpoint
Morphine consumption in the first 24 hours after spine surgery by anterior approach
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Therapeutic, prospective, randomized, double blind, placebo-controlled, in intention to treat, monocentric study to evaluate the analgesic efficacy of a bilateral TAP block after spine surgery with 24 hours morphine consumption

Detailed Description

ALIF is a commonly performed procedure for the treatment of degenerative diseases of the lumbar spine or spondylolisthesis. This technique has many advantages attributed to the absence of posterior spinal muscular pain, a more direct visualization of the disk space, lower incidence of neurological injuries... However, patients experienced moderate to high post operative parietal abdominal pain due to this specific anterior approach. The systematic need for opioids administration may cause many complications and delay the post operative recovery time. The TAP block has been described as an effective pain control technique after various lower abdominal surgeries, reducing both pain scores and 24 hours opioids consumption. However the analgesic efficacy of this technique on specific parietal abdominal pain experienced after spine surgery by anterior approach is not clear

Registry
clinicaltrials.gov
Start Date
November 7, 2016
End Date
May 25, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Rennes University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with age above 18 years old
  • Patients scheduled for spine surgery by anterior approach
  • Patient who signed an informed consent form

Exclusion Criteria

  • Allergy to ropivacaine
  • Weight \< 50 kg
  • Contra indication to TAP block : sepsis in the point of draining, bleeding disorder
  • Contra indication to paracetamol: severe hepatic insufficiency
  • Contra indication to ketoprofen: age ≥ 75 years, renal insufficiency, previous gastric ulcer, allergy
  • Contra indication to nefopam: severe cardiac insufficiency, glaucoma, prostate hypertrophy, allergy
  • Known allergy to active substance or at least to one excipient (propofol, paracetamol, morphine, remifentanil, cisatracurium)
  • Allergy to fentanyl, atracurium, or benzin sulfonic acid derivative, to propacetamol
  • Convulsions or previous convulsive disorder
  • Severe respiratory insufficiency

Arms & Interventions

TAP block ropivacaine

Bilateral ultrasound guided with 15 ml ropivacaine 5mg/ml on each side under general anesthesia at the end of the intervention

Intervention: TAP block ropivacaine

TAP block ropivacaine

Bilateral ultrasound guided with 15 ml ropivacaine 5mg/ml on each side under general anesthesia at the end of the intervention

Intervention: General anesthesia

TAP block placebo

Bilateral ultrasound guided with 15 ml saline on each side under general anesthesia at the end of the intervention

Intervention: TAP block placebo

TAP block placebo

Bilateral ultrasound guided with 15 ml saline on each side under general anesthesia at the end of the intervention

Intervention: General anesthesia

Outcomes

Primary Outcomes

Morphine consumption in the first 24 hours after spine surgery by anterior approach

Time Frame: 24 hours

Secondary Outcomes

  • Morphine consumption in the first 48 hours after spine surgery by anterior approach(48 hours)
  • Delay before the first lift(Day 1)
  • Assessment of pain(1, 6, 12, 24 and 48 hours)
  • Assessment of post operative nausea or vomiting(48 hours)
  • Delay before first morphine administration(Day 1)
  • Delay before resumption of transit(Day 1)
  • Duration of hospitalization(Day 1)
  • Patient satisfaction(48 hours)

Study Sites (1)

Loading locations...

Similar Trials